440 related articles for article (PubMed ID: 33838673)
1. Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial.
Mansour A; Mohajeri-Tehrani MR; Samadi M; Qorbani M; Merat S; Adibi H; Poustchi H; Hekmatdoost A
Nutr J; 2021 Apr; 20(1):35. PubMed ID: 33838673
[TBL] [Abstract][Full Text] [Related]
2. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
[TBL] [Abstract][Full Text] [Related]
3. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
4. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
Nikbaf-Shandiz M; Tutunchi H; Khoshbaten M; Nazari Bonab H; Ebrahimi-Mameghani M
Food Funct; 2022 Nov; 13(22):11568-11578. PubMed ID: 36263703
[TBL] [Abstract][Full Text] [Related]
5. Short term effects of coffee components consumption on gut microbiota in patients with non-alcoholic fatty liver and diabetes: A pilot randomized placebo-controlled, clinical trial.
Mansour A; Mohajeri-Tehrani MR; Karimi S; Sanginabadi M; Poustchi H; Enayati S; Asgarbeik S; Nasrollahzadeh J; Hekmatdoost A
EXCLI J; 2020; 19():241-250. PubMed ID: 32256270
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
[TBL] [Abstract][Full Text] [Related]
7. The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
Kazemi S; Shidfar F; Ehsani S; Adibi P; Janani L; Eslami O
Complement Ther Clin Pract; 2020 Nov; 41():101259. PubMed ID: 33190008
[TBL] [Abstract][Full Text] [Related]
8. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
[TBL] [Abstract][Full Text] [Related]
9. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
[TBL] [Abstract][Full Text] [Related]
10. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial.
Hosseinabadi S; Rafraf M; Asghari S; Asghari-Jafarabadi M; Vojouhi S
Complement Ther Med; 2020 Mar; 49():102290. PubMed ID: 32147076
[TBL] [Abstract][Full Text] [Related]
11. Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.
Loomba R; Morgan E; Watts L; Xia S; Hannan LA; Geary RS; Baker BF; Bhanot S
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):829-838. PubMed ID: 32553151
[TBL] [Abstract][Full Text] [Related]
12. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
[TBL] [Abstract][Full Text] [Related]
13. Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men.
Lecoultre V; Carrel G; Egli L; Binnert C; Boss A; MacMillan EL; Kreis R; Boesch C; Darimont C; Tappy L
Am J Clin Nutr; 2014 Feb; 99(2):268-75. PubMed ID: 24257718
[TBL] [Abstract][Full Text] [Related]
14. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
[TBL] [Abstract][Full Text] [Related]
15. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
Eriksson JW; Lundkvist P; Jansson PA; Johansson L; Kvarnström M; Moris L; Miliotis T; Forsberg GB; Risérus U; Lind L; Oscarsson J
Diabetologia; 2018 Sep; 61(9):1923-1934. PubMed ID: 29971527
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
Mirhafez SR; Azimi-Nezhad M; Dehabeh M; Hariri M; Naderan RD; Movahedi A; Abdalla M; Sathyapalan T; Sahebkar A
Adv Exp Med Biol; 2021; 1308():25-35. PubMed ID: 33861434
[TBL] [Abstract][Full Text] [Related]
17. Increased Intake of Both Caffeine and Non-Caffeine Coffee Components Is Associated with Reduced NAFLD Severity in Subjects with Type 2 Diabetes.
Coelho M; Patarrão RS; Sousa-Lima I; Ribeiro RT; Meneses MJ; Andrade R; Mendes VM; Manadas B; Raposo JF; Macedo MP; Jones JG
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615664
[TBL] [Abstract][Full Text] [Related]
18. The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.
Zamani N; Shams M; Nimrouzi M; Zarshenas MM; Abolhasani Foroughi A; Fallahzadeh Abarghooei E; Fattahi MR
Complement Ther Med; 2018 Dec; 41():118-123. PubMed ID: 30477827
[TBL] [Abstract][Full Text] [Related]
19. Altilix
Castellino G; Nikolic D; Magán-Fernández A; Malfa GA; Chianetta R; Patti AM; Amato A; Montalto G; Toth PP; Banach M; Cicero AFG; Rizzo M
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31731527
[TBL] [Abstract][Full Text] [Related]
20. Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation.
Velázquez AM; Roglans N; Bentanachs R; Gené M; Sala-Vila A; Lázaro I; Rodríguez-Morató J; Sánchez RM; Laguna JC; Alegret M
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
